125 related articles for article (PubMed ID: 16383300)
1. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
[TBL] [Abstract][Full Text] [Related]
2. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer.
Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH
Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
5. [Expression and mutation of β-catenin in non-small cell lung cancer].
Xu H; Lin D; Wang L; Liu N; Wang E
Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):409-13. PubMed ID: 21244793
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic significance in imprints of non-small cell lung cancer.
Chelidonis G; Kavantzas N; Patsouris E; Pagaki E; Athanasiadou AM; Agrogiannis G; Athanasiadou P
Anal Quant Cytol Histol; 2009 Oct; 31(5):332-9. PubMed ID: 20701101
[TBL] [Abstract][Full Text] [Related]
10. Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.
Wei Q; Zhao Y; Yang ZQ; Dong QZ; Dong XJ; Han Y; Zhao C; Wang EH
Lung Cancer; 2008 Nov; 62(2):181-92. PubMed ID: 18692936
[TBL] [Abstract][Full Text] [Related]
11. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
12. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
13. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
16. Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.
Xu HT; Xie XM; Li QC; Liu SL; Dai SD; Liu Y; Wang EH
APMIS; 2013 Feb; 121(2):111-9. PubMed ID: 23030416
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S
Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947
[TBL] [Abstract][Full Text] [Related]
19. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of Frat and beta-catenin in lung cancer and their clinicopathological correlations.].
Luan L; Zhang Y; Guo N; Wang E
Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):62-6. PubMed ID: 20727269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
